Greenwich LifeSciences reports 33% increase in FLAMINGO-01 screening rate Mar 3, 2026 06:01AM
Greenwich LifeSciences Announces Acceptance of Two Abstracts at AACR Annual Meeting 2026 Feb 24, 2026 06:01AM
H.C. Wainwright Reiterates Buy Rating on Greenwich LifeSciences (GLSI) Feb 5, 2026 06:50AM
Greenwich LifeSciences raises cash balance to $12.5 million through ATM Jan 27, 2026 06:00AM
Greenwich LifeSciences extends director lock-up to September 2026 Dec 29, 2025 06:01AM


Dec 22, 2025 06:00AM Greenwich LifeSciences reports progress on FLAMINGO-01 breast cancer trial
Dec 15, 2025 06:01AM Greenwich LifeSciences reports 80% recurrence reduction in cancer trial
Dec 8, 2025 06:02AM Greenwich LifeSciences completes enrollment in open label arm of phase III trial
Dec 3, 2025 06:00AM Greenwich LifeSciences screens over 1,000 patients in phase III trial
Oct 9, 2025 06:00AM Greenwich LifeSciences adds Austria to Phase III breast cancer trial
Oct 2, 2025 06:00AM Greenwich LifeSciences expands breast cancer trial to Belgium
Sep 30, 2025 06:01AM Greenwich LifeSciences expands FLAMINGO-01 trial to Portugal
Sep 18, 2025 06:01AM Greenwich LifeSciences expands breast cancer trial to Ireland
Aug 20, 2025 09:28AM Noble Capital Starts Greenwich LifeSciences (GLSI) at Outperform
Aug 19, 2025 06:01AM Greenwich LifeSciences builds internal clinical operations team
Aug 13, 2025 06:00AM Greenwich LifeSciences expands breast cancer trial to Romania
Jun 27, 2025 09:00AM Greenwich LifeSciences Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Apr 21, 2025 06:44AM Greenwich LifeSciences (GLSI) PT Raised to $39 at H.C. Wainwright
Apr 3, 2025 08:02AM Greenwich LifeSciences (GLSI) Provides Global Update on FLAMINGO-01
Apr 2, 2025 06:26AM Greenwich LifeSciences (GLSI) Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
Mar 17, 2025 06:45AM Greenwich LifeSciences (GLSI) Provides Update on Open Label Safety Data from FLAMINGO-01
Feb 10, 2025 06:00AM Greenwich LifeSciences (GLSI) Provides Update on Open Label HLA Data from FLAMINGO-01
Jan 22, 2025 06:03AM Greenwich LifeSciences (GLSI) Provides Update on Commercial Manufacturing
Jan 14, 2025 06:15AM Greenwich LifeSciences (GLSI) Announces Partnership with GBG in Germany for Flamingo-01
Aug 1, 2024 06:25AM Greenwich LifeSciences (GLSI) Provides Update on Expansion of Flamingo-01 into Spain
Jun 26, 2024 07:33AM Greenwich LifeSciences (GLSI) to Rejoin Russell 2000 Index
Jun 14, 2024 06:01AM Greenwich LifeSciences (GLSI) Announces 175K Private Placement at $14.30/sh